Oramed Pharmaceuticals
ORMP
#9130
Rank
C$0.22 B
Marketcap
C$5.49
Share price
2.37%
Change (1 day)
87.63%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): C$1.13

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$1.15. In 2024 the company made an earnings per share (EPS) of C-$0.68 a decrease over its 2023 EPS that were of C$0.20.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$1.13-266.02%
2024C-$0.68-442.86%
2023C$0.20-114.89%
2022C-$1.3320.51%
2021C-$1.1039.29%
2020C-$0.79-31.71%
2019C-$1.16-4.65%
2018C-$1.228.86%
2017C-$1.12-9.2%
2016C-$1.2329.85%
2015C-$0.958.06%
2014C-$0.885.08%
2013C-$0.833.51%
2012C-$0.81137.5%
2011C-$0.34-60%
2010C-$0.85-0%
2009C-$0.85-16.67%
2008C-$1.02-25%
2007C-$1.36700%
2006C-$0.17303.56%
2005C-$0.04208

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
C$6.08 430.30%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$3.62 216.01%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C-$8.65-854.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.27-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C-$0.42-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel